EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycosylation Modulation Dictates Trafficking and Interaction of SARS-CoV-2 S1 Subunit and ACE2 in Intestinal Epithelial Caco-2 Cells

Marianne El Khoury, Dalanda Wanes iD, Maura Lynch-Miller iD, Abdullah Hoter, Hassan Y Naim iD

Biomolecules · 2024

DOI: 10.3390/biom14050537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Marianne El Khoury und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Spike Glycoprotein, Coronavirus, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mainly targets the upper respiratory tract. It gains entry by interacting with the host cell receptor angiotensin-converting enzyme 2 (ACE2) via its heavily glycosylated spike glycoprotein. SARS-CoV-2 can also affect the gastrointestinal tract. Given the significant role of glycosylation in the life cycle of proteins and the multisystem target of SARS-CoV-2, the role of glycosylation in the interaction of S1 with ACE2 in Caco-2 cells was investigated after modulation of their glycosylation patterns using N-butyldeoxynojirimycin (NB-DNJ) and 1-deoxymannojirimycin (dMM), in addition to mutant CHO cells harboring mutations at different stages of glycosylation. The data show a substantial reduction in the interactions between the altered glycosylation forms of S1 and ACE2 in the presence of NB-DNJ, while varied outcomes resulted from dMM treatment. These results highlight the promising effects of NB-DNJ and its potential use as an off-label drug to treat SARS-CoV-2 infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2Spike Glycoprotein, CoronavirusSARS-CoV-2HumansCaco-2 CellsGlycosylationAnimalsCHO CellsCricetulusProtein TransportCOVID-191-DeoxynojirimycinProtein BindingIntestinal Mucosa

Stichwörter der Autor:innen

N-butyldeoxynojirimycinSARS-CoV-2glycosylationprotein traffickingprotein–protein interaction

Substanzen

Angiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2 protein, human1-Deoxynojirimycin

Autor:innen und Institutionen

  • Department of Biochemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.

ORCID-Profile: Dalanda Wanes, Maura Lynch-Miller, Hassan Y Naim

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

El Khoury, M., Wanes, D., Lynch-Miller, M., Hoter, A., & Naim, H. Y. (2024). Glycosylation Modulation Dictates Trafficking and Interaction of SARS-CoV-2 S1 Subunit and ACE2 in Intestinal Epithelial Caco-2 Cells. Biomolecules. https://doi.org/10.3390/biom14050537

Vancouver

El Khoury M, Wanes D, Lynch-Miller M, Hoter A, Naim HY. Glycosylation Modulation Dictates Trafficking and Interaction of SARS-CoV-2 S1 Subunit and ACE2 in Intestinal Epithelial Caco-2 Cells. Biomolecules. 2024. doi:10.3390/biom14050537

BibTeX
@article{ElKhoury2024,
  author = {El Khoury, Marianne and Wanes, Dalanda and Lynch-Miller, Maura and Hoter, Abdullah and Naim, Hassan Y},
  title = {Glycosylation Modulation Dictates Trafficking and Interaction of SARS-CoV-2 S1 Subunit and ACE2 in Intestinal Epithelial Caco-2 Cells},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14050537}
}
Kostenlos starten →